All News #Library
Others
Lyvgen and BMS partner for Phase II lung cancer antibody trial
28 Nov 2022 //
CLINICALTRIALSARENA
Lyvgen Announces Phase 2 Clinical Collaboration with BMS to Evaluate LVGN7409
27 Nov 2022 //
PRNEWSWIRE

Market Place
Sourcing Support